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It has been generally known that patients of higher age suffer from more diseases. Pa­
tients above 8o years of age are treated for more than 2 chronic diseases in 8o %. The ten­
dency to treat all known diseases of our patients means accumulation of the drugs used. In 
our previous studies we found the average number of daily used types of drugs to equal 
4 -  5 (i) (see Graph No. l).
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We divided our group of patients according to age and did not find any significant dif­
ferences in the number of drugs used, even if we considered patients with the highest number 
of drugs used -  see Graph No. 2. Women tended to use more kinds of drugs -  see Graph No. 3.
It is not easy to establish a limit for the “adequate” number of drugs used in the eld­
erly population. The term polypragmasy can be quite relative in this group of patients. If we 
consider a very common combination of diseases in the elderly man -  ischaemic heart dis­
ease, diabetes mellitus, hypertension, and spondylosis -  the basic therapy comprises 6 types
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of drugs at least. The situation in women concerning the number of drugs taken is very simi­
lar -  if we consider, e.g., ischaemic heart disease, osteoporosis, and hypochromia.
Similar results can be found in the literature -  the authors from Denmark published 
study results of interviews with patients just discharged from the hospital. The theme of these 
interviews was medication. The average number of the used types of drugs was 8 daily, rang­
ing from l  to 24. As regards the number of drugs stored at home, the average number was 9, 
though ranging from 1 up to 44 (2).
Graph No. 2
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To have an overview of the patient’s medication, we have to consider yet other in­
fluences -  publicity, families, neighbours, etc., undoubtedly increasing the amount of 
drugs used by over-the-counter drugs. However, patient?s information usually does not 
comprise these drugs. The aim of our small study was to realize, how much OTC drugs 
buy our patients
Patients characteristics and methods. We have arranged a simple study in 
co-operation with general practitioners -  contracted teachers of the Faculty of Medicine 
of M asaryk University in Brno. Medical students of the 6th year spend a 2-week stay at 
the GP’s office as part of their study programme. Our students interviewed elderly pa­
tients on OTCs usage from 2001 to 2005. The questions were aimed at the number, types 
and price of OTCs, and additional payments for prescribed drugs.
Results. The results were surprising. There were 400 responders, 252 women 
and 148 men of average age 78,7+4,2 years. The average number of regularly bought 
OTCs was 2,26+1,79 at the beginning and 2,32+2,25 et the end of the study. Alm ost 60 % 
o f elderly patients have been buying vitamins, 30 % nonsteroidal anti-inflamm atory 
drugs, and 43 % of seniors have been buying analgesics -  see graph No. 4.
Concerning the frequency of purchases, vitamins and nonsteroidal antirheumatics 
were bought on regular basis -  monthly or weekly, other groups of medicaments occasionally 
or exceptionally.
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InHX J T k
НАУЧНЫЕ ВЕДОМОСТИ ЩШ Серия Медицина. Фармация. 2010. № 22 (93). Выпуск 12/1 113
Graph No. 3
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The difference between men and women was interesting -  women bought signifi­
cantly less laxatives and significantly more vitamins -  see graph No. 5.
Graph No. 4
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The increase of OTCs purchases was about 10 % during our study (from 2001 to 
2005), and only 5 % in vitamins. This development is influenced by changes in the health in­
surance system and the ensuing increase of additional payments on the one hand, and, on the 
other, by increasing availability of OTCs on the market. The average amount of money spent 
monthly for OTCs increased from 93 CZK to 114 CZK, which is 20 % more. Additional pay­
ments for prescribed drugs were monthly 95 CZK in 2001 and 152 CZK in 2005, which means 
a 60 % increase. The maximum additional payment rose monthly from 750 CZK to 1500 CZK, 
the maximum monthly cost for OTCs rose from 670 CZK in 2001 to 870 CZK in 2005.
Surprisingly, we did not find any negative correlation between additional pay­
ments for prescribed drugs and costs for OTCs. On the contrary -  patients with higher
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additional payments for prescribed drugs tended to buy more OTCs. The average number 
of OTCs taken was 2.2 types in our group of patients.
Graph No. 5
OTCs purchases according to gender.
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Discussion Results of our study did not differ from studies done in other coun­
tries -  there is not usual in our country among physicians and patients as well to consider 
OTCs as a normal part of treatm ent schedule and to discuss the use of them freely. The 
positive impact is the patient?s activity to improve his health status and to have more in­
formation about his disease, however the general practitioner and/or specialist should be 
informed about taken OTCs to be able to create the comprehensive therapeutic scheme. 
On the other hand there is possible to observe a little bit nonsense situation -  patients are 
discussing thoroughly about few crowns of additional payment and im m ediately they 
spend hundreds of crowns for OTCs.
Conclusions of Italian and british authors show interesting ways how to decrease 
costs of prescribed drugs and OTCs as well. Altogether 70% of patients consider their 
costs of medications as important. The easiest way how to decrease the amount of money 
spent for medications is to abandon prescribed drugs and not to take them from the 
pharmacy. Italian patients have to pay lower additional payments, so they prefer physi­
c ia n s  prescription. Additional payments for medications are higher in Great BritainBrit- 
ish, so patients prefer to buy OTCs (3).
We have to consider OTCs as a substantial part of pharm acotherapy of our pa­
tients. We must take into account a possible potentiation of the interactions and un­
wanted side effects as the cause of unclear worsening of the patient’s health status. Pa­
tients usually do not inform their physicians about the OTCs used for different reasons. 
Our experience is similar to the results of American and Canadian authors showing 33% 
of patients in Canada and 20% patients in United States don’t inform their general practi­
tioner about use of OTCs (4).
Our patients frequently do not rate OTCs as full-value medicaments because of 
their labelling as food supplements, mostly due to the politics of pharmaceutical compa­
nies to penetrate more simply the market. An overview of the potent influence of OTCs 
can be obtained by comparing payments in drugstores in hospitals and downtown: hospi­
tal pharmacists report OTCs as 20-30 % of the sales, drugstores downtown up to 80 %.
The most frequent impulse to buy OTCs is painful form of osteroarthrosis in eld­
erly patients, they prefer nonsteroid antirevmatics in comparison with simple analgetics. 
The effectivity of treatm ent must be evaluated with regard to possible complications -  
gastrointestinal bleeding, nefrotoxicity, haematological complications (5).
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The alcohol consumption must be taken into account in elderly -  different authors 
present up to 44% seniors drinking alkohol, most of them on regular basis, but we are not 
accustomed until now to include this fact into our calculations of possible drug interac­
tons for example in antihypertensive or antiarrythmic therapy or the complex influence 
by cytochrome P450 activation (6).
The main risk of multiple pharm acotherapy is the increasing number of unwanted 
side effects. If our patients use 6 types of drugs, we have to expect unwanted side effects 
in each tenth -  see graph No. 6. From the point of view of interactions we have to con­
sider an exponential increase -  thus with 6 used medicaments 40-50 interactions can ap­
pear -  see graph No 6. Not all of these interactions are clinically serious, of course. The 
results of many studies prove that the higher is the number of medications used, the 
higher is the number of mistakes and the worse is the patient’s compliance (7). All these 
facts underline the everyday experience -  up to 28 % of the hospitalisations of elderly pa­
tients are caused by mistakes, unwanted side effects, and interactions in their pharm aco­
therapy (8).
Graph No. 6
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Our attention should be paid not only to OTC medications and food supplements but 
also to natural, mostly plant products. Our patients prefer these products frequently as natu­
ral and “certainly harmless”. We already know for a long time that plants can be contami­
nated by pesticides and moulds, while the composition of these products is inconstant ac­
cording to place and soil parameters. Any plant product comprises many chemical compo­
nents, which can increase substantially the number of interactions and side effects. The re­
sults of a study conducted in Denmark showed that 14 % of men and 22 % of women have 
been using natural products. No relationship was found to the level of education (9). Signifi­
cantly higher number of patients with more diseases tended to use more plant products -  this 
finding is similar to our study results.
Another study estimated the reasons of kidney damage by plant products. As main de­
ficiencies were detected errors in plant determination, errors in extract preparation, lack of 
information about the substance and its interactions, and lack of specialised supervision dur­
ing the preparation process (10, 11).
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_____ Conclusions for practice:______________________________________
be interested in OTCs used by your patient;
obtain objective information in co-operation with the patient’s relatives 
and friends;
in case of unsuitable combinations explain the risks to your patient, 
discussing further strategy;
be informed basically about OTCs even if you yourself do not prescribe 
them and do not recommend them.
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